Sulfonamide antibiotics inhibit RNAi by binding to human Argonaute protein 2 PAZ

Bioorg Med Chem Lett. 2020 Dec 15;30(24):127637. doi: 10.1016/j.bmcl.2020.127637. Epub 2020 Oct 22.

Abstract

We found that sulfisomidine, a sulfonamide antibiotic, potently binds to the Piwi/Argonaute/Zwille (PAZ) domain of human Argonaute protein 2 and inhibits RNA interference (RNAi). To elucidate the effect on RNAi of strong affinity of the 3'-ends in small interfering RNA (siRNA) to the PAZ domain, chemically modified siRNAs bearing sulfisomidine at the 3'-end were synthesized.

Keywords: Ago2; PAZ domain; RNAi; Sulfonamide antibiotics; siRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Argonaute Proteins / chemistry
  • Argonaute Proteins / metabolism*
  • Humans
  • Protein Domains / drug effects
  • RNA Interference / drug effects*
  • RNA, Small Interfering / antagonists & inhibitors
  • Sulfisomidine / pharmacology*
  • Sulfonamides / pharmacology

Substances

  • AGO2 protein, human
  • Anti-Bacterial Agents
  • Argonaute Proteins
  • RNA, Small Interfering
  • Sulfonamides
  • Sulfisomidine